These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1262943)

  • 1. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate.
    Khentigan A; Garrett M; Lum D; Winchell HS
    J Nucl Med; 1976 May; 17(5):380-4. PubMed ID: 1262943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in tissue distribution of 99mTc-pertechnetate in rats given stannous tin.
    McRae J; Sugar RM; Shipley B; Hook GR
    J Nucl Med; 1974 Mar; 15(3):151-5. PubMed ID: 4813221
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of preloading of stannous compounds on the distribution of 99mTc-pertechnetate.
    Greenberg DD; Som P; Meinken GE; Sacker DF; Atkins HL
    Nuklearmedizin; 1977 Feb; 16(1):26-9. PubMed ID: 191793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
    Tofe AJ; Francis MD
    J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tin on the tissue distribution of 99mTc-sodium pertechnetate.
    Ancri D; Lonchampt MF; Basset JY
    Radiology; 1977 Aug; 124(2):445-50. PubMed ID: 877283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic imaging with 99mTc-labeled erythrocytes: a comparative study of cell-damaging methods.
    Hamilton RG; Alderson PO; Harwig JF; Siegel BA
    J Nucl Med; 1976 Dec; 17(12):1038-43. PubMed ID: 993833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complexes 99mTc-Sn-DTPA, 99mTc-Fe-ascorbic acid, and 99mTc-Sn-calcium-gluconogalactogluconate in the diagnosis of renal function and morphology (author's transl)].
    Licińska I; Graban W; Jakubowski W; Krasucki T; Lachnik E; Wiza J; Zulczyk W; Smoliński S; Zielińska B
    Pol Przegl Radiol Med Nukl; 1977; 41(1):57-61. PubMed ID: 859758
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying effect of commercially available stannous pyrophosphate (PYRO-Sn) on the tissue affinity of 99mTc pertechnetate.
    Bałtrukiewicz Z; Przedlacki J; Dziuk E
    Eur J Nucl Med; 1980; 5(1):45-7. PubMed ID: 7379805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal concentration of 99mTc-pertechnetate into isolated loops of rat bowel.
    Taylor AT; Alazraki N; Henry JE
    J Nucl Med; 1976 Jun; 17(6):470-2. PubMed ID: 1262964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gated blood pool imaging following 99mTc stannous pyrophosphate imaging.
    Stokely EM; Parkey RW; Bonte FJ; Graham KD; Stone MJ; Willerson JT
    Radiology; 1976 Aug; 120(2):433-4. PubMed ID: 935500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell labelling by intravenous injection of 99mTc-PAEP.
    Varvarigou A; Chiotellis E; Vavouraki H
    Nuklearmedizin; 1984 Feb; 23(1):29-30. PubMed ID: 6328452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible artifact in gel chromatography of some 99m Tc-chelates.
    Valk PE; Dilts CA; McRae J
    J Nucl Med; 1973 Apr; 14(4):235-7. PubMed ID: 4691415
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficiency of in vivo labeling of red blood cells with 99mTc.
    Colombetti LG; Siddiqui A
    Nuklearmedizin; 1976 Oct; 15(5):211-3. PubMed ID: 1005126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling and testing of 99mTc-streptokinase for the diagnosis of deep vein thrombosis.
    Persson BR; Kempi V
    J Nucl Med; 1975 Jun; 16(6):474-7. PubMed ID: 1159502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New preparation method for 99mTc-phytate.
    Ikeda I; Inoue O; Kurata K
    J Nucl Med; 1976 May; 17(5):389-93. PubMed ID: 1262944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroaggregation of an albumin-stabilized technetium-tin(II) colloid.
    Lin MS; Winchell HS
    J Nucl Med; 1972 Dec; 13(12):928-31. PubMed ID: 5087165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.